Werner Lesslauer

Werner Lesslauer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Werner Lesslauer sits on this spectrum.

Werner Lesslauer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Werner Lesslauer sits on this spectrum.

Best Publications

• THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR

  Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden

  1744
  Citations

• Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

  Joachim Rothe;Werner Lesslauer;Hansruedi Lötscher;Yolande Lang

  1536
  Citations

• Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

  David W. Banner;Allan D'Arcy;Wolfgang Janes;Reiner Gentz

  1528
  Citations

• Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

  Hansruedi Loetscher;Yu-Ching E. Pan;Hans-Werner Lahm;Reiner Gentz

  1322
  Citations

• Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

  Manfred Brockhaus;Hans-Joachim Schoenfeld;Ernst-Juergen Schlaeger;Willi Hunziker

  1046
  Citations

• Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

  Fabienne Mackay;Hansruedi Loetscher;Dietrich Stueber;Gisela Gehr

  504
  Citations

• Blockade of p38 Mitogen-activated Protein Kinase Pathway Inhibits Inducible Nitric-oxide Synthase Expression in Mouse Astrocytes

  Jean Da Silva;Benoit Pierrat;Jean-Luc Mary;Werner Lesslauer

  432
  Citations

• Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

  Edward Abraham;Pierre-François Laterre;Jorge Garbino;Susan Pingleton

  405
  Citations

• TWO HUMAN TNF RECEPTORS HAVE SIMILAR EXTRACELLULAR, BUT DISTINCT INTRACELLULAR, DOMAIN SEQUENCES

  Zlatko Dembic;Hansruedi Loetscher;Ueli Gubler;Yu-Ching E. Pan

  352
  Citations

• Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.

  H Loetscher;D Stueber;D Banner;F Mackay

  340
  Citations

• Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.

  Werner Lesslauer;Hisahiro Tabuchi;Reiner Gentz;Manfred Brockhaus

  332
  Citations

• Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.

  P F Piguet;G E Grau;C Vesin;H Loetscher

  311
  Citations

• Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase

  Danielle L. Drayton;Xiaoyan Ying;Jason Lee;Werner Lesslauer

  284
  Citations

• Human TNF mutants with selective activity on the p55 receptor

  Xaveer Van Ostade;Peter Vandenabeele;Bart Everaerdt;Hansruedi Loetscher

  283
  Citations

• Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.

  L Mori;S Iselin;G De Libero;W Lesslauer

  261
  Citations

• Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.

  H. Loetscher;R. Gentz;M. Zulauf;A. Lustig

  251
  Citations

• Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors

  M R Shalaby;A Sundan;H Loetscher;M Brockhaus

  229
  Citations

• Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.

  G Gehr;R Gentz;M Brockhaus;H Loetscher

  227
  Citations

• Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.

  T J Evans;D Moyes;A Carpenter;R Martin

  206
  Citations

• TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview

  W.E.F Klinkert;K Kojima;W Lesslauer;W Rinner

  203
  Citations